A meta-analysis of 18 studies found that late diagnosis and mortality were significantly higher among American women than African women.

First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer.

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.

After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.

But this benefit applied only to those individuals who initiated aspirin use at an earlier age.

Study shows that screening kits from a drive-by flu vaccination clinic increased access to colorectal cancer screening for Black Americans

Altering gut bacteria may help overcome resistance to checkpoint inhibitors in people with melanoma and other cancers.

More than 80% of lung cancer patients treated with the targeted therapy experienced remission or had stable disease.

Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.